Related Experiment Video
Updated: Jan 29, 2026

Real Time Monitoring of Intracellular Bile Acid Dynamics Using a Genetically Encoded FRET-based Bile Acid Sensor
Published on: January 4, 2016
FGF15 Activates Hippo Signaling to Suppress Bile Acid Metabolism and Liver Tumorigenesis
Suyuan Ji1, Qingxu Liu1, Shihao Zhang1
1State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian 361102, China; Cancer Research Center of Xiamen University, Xiamen, Fujian 361102, China.
Abstract:
The external factors that modulate Hippo signaling remain elusive. Here, we report that FGF15 activates Hippo signaling to suppress bile acid metabolism, liver overgrowth, and tumorigenesis. FGF15 is induced by FXR in ileal enterocytes in response to increased amounts of intestinal bile. We found that circulating enterohepatic FGF15 stimulates hepatic receptor FGFR4 to recruit and phosphorylate NF2, which relieves the inhibitory effect of Raf on the Hippo kinases Mst1/2, thereby switching FGFR4's role from pro-oncogenic to anti-tumor signaling. The activated Mst1/2 subsequently phosphorylates and stabilizes SHP to downregulate the key bile acid-synthesis enzyme Cyp7a1 expression, thereby limiting bile acid synthesis. In contrast, Mst1/2 deficiency impairs bile acid metabolism and remarkably increases Cyp7a1 expression and bile acid production. Importantly, pharmacological depletion of intestinal bile abrogates Mst1/2-mutant-driven liver overgrowth and oncogenesis. Therefore, FGF15-Hippo signaling along the gut-liver axis acts as a sensor of bile acid availability to restrain liver size and tumorigenesis.
Insights
Fibroblast growth factor 15 (FGF15) activates Hippo signaling to control bile acid metabolism and prevent liver overgrowth and tumors. This pathway acts as a key sensor for bile acid levels, maintaining liver health.
Area of Science:
- Cellular signaling pathways
- Hepatology
- Gastroenterology
Background:
- The external regulators of Hippo signaling are not well understood.
- Hippo signaling plays a crucial role in organ size control and tumor suppression.
Purpose of the Study:
- To investigate the role of FGF15 in modulating Hippo signaling.
- To elucidate the mechanism by which FGF15 regulates bile acid metabolism and liver homeostasis.
Main Methods:
- Investigated FGF15 induction by FXR in response to bile acids.
- Examined the interaction of FGF15 with FGFR4, NF2, and Raf in hepatic cells.
- Assessed the impact of Mst1/2 activation on SHP and Cyp7a1 expression.
- Utilized pharmacological bile acid depletion in Mst1/2-deficient models.
Main Results:
- FGF15, induced by FXR, activates Hippo signaling via FGFR4, NF2, and Raf.
- Activated Mst1/2 phosphorylates and stabilizes SHP, downregulating Cyp7a1 expression and bile acid synthesis.
- Mst1/2 deficiency leads to impaired bile acid metabolism and increased bile acid production.
- Depletion of intestinal bile abrogates Mst1/2-mutant-driven liver overgrowth and oncogenesis.
Conclusions:
- FGF15-Hippo signaling acts as a crucial gut-liver axis sensor for bile acid availability.
- This pathway effectively restrains liver size and suppresses tumorigenesis by regulating bile acid metabolism.
More Related Videos
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
What is Metabolism?
Bile
Bile is released when dietary fats enter...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...

